Total Phenolic Fraction (TPF) from Extra Virgin Olive Oil: Induction of apoptotic-like cell death in Leishmania spp. promastigotes and in vivo potential of therapeutic immunomodulation.
Animals
Antibodies
Cell Cycle
Cell Death
/ drug effects
Cytokines
Diet, Mediterranean
Female
Gene Expression
Immunoglobulin G
Immunomodulation
Inhibitory Concentration 50
Kinetics
Leishmania
/ drug effects
Leishmaniasis, Cutaneous
/ drug therapy
Macrophages
/ immunology
Mice, Inbred BALB C
Mitochondria
/ metabolism
Olive Oil
/ pharmacology
Phenols
/ pharmacology
Th1 Cells
Th2 Cells
Journal
PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
received:
17
07
2020
accepted:
09
11
2020
entrez:
11
1
2021
pubmed:
12
1
2021
medline:
18
5
2021
Statut:
epublish
Résumé
Leishmaniasis is a serious multifactorial parasitic disease with limited treatment options. Current chemotherapy is mainly consisted of drugs with serious drawbacks such as toxicity, variable efficacy and resistance. Alternative bioactive phytocompounds may provide a promising source for discovering new anti-leishmanial drugs. Extra Virgin Olive Oil (EVOO), a key-product in the Mediterranean diet, is rich in phenols which are associated with anti-inflammatory, anti-cancer and anti-microbial effects. In this study, we investigate the anti-leishmanial effect of Total Phenolic Fraction (TPF) derived from EVOO in both in vitro and in vivo systems by investigating the contributing mechanism of action. We tested the ability of TPF to cause apoptotic-like programmed cell death in L. infantum and L. major exponential-phase promastigotes by evaluating several apoptotic indices, such as reduction of proliferation rate, sub-G0/G1 phase cell cycle arrest, phosphatidylserine externalization, mitochondrial transmembrane potential disruption and increased ROS production, by using flow cytometry and microscopy techniques. Moreover, we assessed the therapeutic effect of TPF in L. major-infected BALB/c mice by determining skin lesions, parasite burden in popliteal lymph nodes, Leishmania-specific antibodies and biomarkers of tissue site cellular immune response, five weeks post-treatment termination. Our results show that TPF triggers cell-cycle arrest and apoptotic-like changes in Leishmania spp. promastigotes. Moreover, TPF treatment induces significant reduction of parasite burden in draining lymph nodes together with an antibody profile indicative of the polarization of Th1/Th2 immune balance towards the protective Th1-type response, characterized by the presence of IFN-γ-producing CD4+ T-cells and increased Tbx21/GATA-3 gene expression ratio in splenocytes. TPF exhibits chemotherapeutic anti-leishmanial activity by inducing programmed cell death on cell-free promastigotes and immunomodulatory properties that induce in vivo T cell-mediated responses towards the protective Th1 response in experimental cutaneous leishmaniasis. These findings enable deeper understanding of TPF's dual mode of action that encourages further studies.
Sections du résumé
BACKGROUND
Leishmaniasis is a serious multifactorial parasitic disease with limited treatment options. Current chemotherapy is mainly consisted of drugs with serious drawbacks such as toxicity, variable efficacy and resistance. Alternative bioactive phytocompounds may provide a promising source for discovering new anti-leishmanial drugs. Extra Virgin Olive Oil (EVOO), a key-product in the Mediterranean diet, is rich in phenols which are associated with anti-inflammatory, anti-cancer and anti-microbial effects. In this study, we investigate the anti-leishmanial effect of Total Phenolic Fraction (TPF) derived from EVOO in both in vitro and in vivo systems by investigating the contributing mechanism of action.
METHODOLOGY/PRINCIPAL FINDINGS
We tested the ability of TPF to cause apoptotic-like programmed cell death in L. infantum and L. major exponential-phase promastigotes by evaluating several apoptotic indices, such as reduction of proliferation rate, sub-G0/G1 phase cell cycle arrest, phosphatidylserine externalization, mitochondrial transmembrane potential disruption and increased ROS production, by using flow cytometry and microscopy techniques. Moreover, we assessed the therapeutic effect of TPF in L. major-infected BALB/c mice by determining skin lesions, parasite burden in popliteal lymph nodes, Leishmania-specific antibodies and biomarkers of tissue site cellular immune response, five weeks post-treatment termination. Our results show that TPF triggers cell-cycle arrest and apoptotic-like changes in Leishmania spp. promastigotes. Moreover, TPF treatment induces significant reduction of parasite burden in draining lymph nodes together with an antibody profile indicative of the polarization of Th1/Th2 immune balance towards the protective Th1-type response, characterized by the presence of IFN-γ-producing CD4+ T-cells and increased Tbx21/GATA-3 gene expression ratio in splenocytes.
CONCLUSIONS/SIGNIFICANCE
TPF exhibits chemotherapeutic anti-leishmanial activity by inducing programmed cell death on cell-free promastigotes and immunomodulatory properties that induce in vivo T cell-mediated responses towards the protective Th1 response in experimental cutaneous leishmaniasis. These findings enable deeper understanding of TPF's dual mode of action that encourages further studies.
Identifiants
pubmed: 33428610
doi: 10.1371/journal.pntd.0008968
pii: PNTD-D-20-01289
pmc: PMC7799795
doi:
Substances chimiques
Antibodies
0
Cytokines
0
Immunoglobulin G
0
Olive Oil
0
Phenols
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0008968Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Vaccine. 2002 Jan 15;20(7-8):1226-31
pubmed: 11803085
Parasitol Res. 2003 Jan;89(2):123-33
pubmed: 12489012
Curr Biol. 2001 Nov 27;11(23):1870-3
pubmed: 11728310
Parasitology. 2018 Apr;145(4):464-480
pubmed: 28103966
Nat Rev Immunol. 2002 Nov;2(11):845-58
pubmed: 12415308
Adv Exp Med Biol. 2010;676:137-47
pubmed: 20687474
J Immunol Methods. 1991 Jun 3;139(2):271-9
pubmed: 1710634
J Med Microbiol. 2012 Dec;61(Pt 12):1709-1718
pubmed: 22956747
Acta Oncol. 1993;32(4):417-24
pubmed: 8369130
Proc Nutr Soc. 2017 Nov;76(4):543-548
pubmed: 28659225
Int J Mol Sci. 2012;13(3):3291-340
pubmed: 22489153
Sci Rep. 2014 Apr 15;4:4698
pubmed: 24732136
Mol Microbiol. 2010 Jul;77(2):399-414
pubmed: 20497506
Molecules. 2016 Dec 16;21(12):
pubmed: 27999296
DNA Repair (Amst). 2006 Feb 3;5(2):145-52
pubmed: 15878696
Parasitol Int. 2001 Jul;50(2):81-91
pubmed: 11438430
Proc Natl Acad Sci U S A. 2006 Sep 12;103(37):13837-42
pubmed: 16945916
Parasitol Res. 2014 Mar;113(3):953-7
pubmed: 24337510
Front Cell Infect Microbiol. 2012 Jul 12;2:96
pubmed: 22912937
Antimicrob Agents Chemother. 2014 Oct;58(10):5916-28
pubmed: 25070112
Parasit Vectors. 2010 Dec 02;3:116
pubmed: 21126352
J Med Microbiol. 2007 Sep;56(Pt 9):1196-1204
pubmed: 17761483
Clin Infect Dis. 2013 Jun;56(11):1530-8
pubmed: 23425958
Parasit Vectors. 2010 Nov 09;3:104
pubmed: 21062457
Braz J Med Biol Res. 2005 Jun;38(6):807-12
pubmed: 15933773
Exp Parasitol. 2015 Jun;153:45-54
pubmed: 25747203
Exp Parasitol. 2011 Jan;127(1):215-21
pubmed: 20691682
Rapid Commun Mass Spectrom. 2010 Jul 30;24(14):2074-82
pubmed: 20552712
PLoS Negl Trop Dis. 2016 Mar 29;10(3):e0004525
pubmed: 27023069
Toxicol Pathol. 2007 Jun;35(4):495-516
pubmed: 17562483
Exp Neurol. 2015 May;267:254-67
pubmed: 25447934
Evid Based Complement Alternat Med. 2015;2015:541591
pubmed: 25802541
Int J Parasitol. 2009 Oct;39(12):1289-303
pubmed: 19445946
PLoS One. 2017 Feb 7;12(2):e0171306
pubmed: 28170432
Mol Microbiol. 2006 Jun;60(6):1457-73
pubmed: 16796681
PLoS Negl Trop Dis. 2010 Oct 26;4(10):e709
pubmed: 21049059
J Biol Chem. 2004 Dec 10;279(50):52366-75
pubmed: 15355995
J Med Microbiol. 2014 Jan;63(Pt 1):74-85
pubmed: 24161990
Parasit Vectors. 2016 Aug 09;9(1):441
pubmed: 27501956
PLoS One. 2012;7(8):e42070
pubmed: 22870283
PLoS One. 2014 May 15;9(5):e97319
pubmed: 24830439
Antimicrob Agents Chemother. 2008 Aug;52(8):2855-60
pubmed: 18519729
Best Pract Res Clin Endocrinol Metab. 2012 Dec;26(6):711-23
pubmed: 23168274
Front Microbiol. 2015 Sep 24;6:1015
pubmed: 26441938
Cell Death Differ. 2002 Jan;9(1):53-64
pubmed: 11803374
J Parasit Dis. 2017 Mar;41(1):76-85
pubmed: 28316391
J Antimicrob Chemother. 2013 Apr;68(4):789-99
pubmed: 23288404
J Immunol Res. 2019 Apr 30;2019:9124326
pubmed: 31183394
Pflugers Arch. 2011 Nov;462(5):693-708
pubmed: 21881871
Evid Based Complement Alternat Med. 2016;2016:9147096
pubmed: 27807464
Anal Bioanal Chem. 2012 Jan;402(3):1169-82
pubmed: 22065347
J Med Microbiol. 2007 Sep;56(Pt 9):1213-1218
pubmed: 17761485
J Immunol Methods. 2003 Jul;278(1-2):157-69
pubmed: 12957404
BMJ Glob Health. 2018 May 3;3(3):e000709
pubmed: 29736277
Antimicrob Agents Chemother. 2019 Jun 24;63(7):
pubmed: 31036692
Exp Parasitol. 2014 Aug;143:18-23
pubmed: 24810433
PLoS One. 2009 May 29;4(5):e5733
pubmed: 19478944
J Lipid Res. 2006 Oct;47(10):2171-8
pubmed: 16861743
J Control Release. 2010 Jan 25;141(2):199-207
pubmed: 19818373
Int J Parasitol. 2003 Mar;33(3):257-67
pubmed: 12670511
BMC Pharmacol. 2001;1:1
pubmed: 11299045
J Infect. 2005 Aug;51(2):157-64
pubmed: 16038768
EMBO J. 2007 Feb 21;26(4):1094-104
pubmed: 17290222
Exp Parasitol. 2014 Feb;137:53-65
pubmed: 24370645
Eur J Biochem. 2000 Sep;267(17):5421-6
pubmed: 10951200
Mol Biol Int. 2011;2011:876021
pubmed: 22091415
Cell Physiol Biochem. 2017;44(2):532-553
pubmed: 29145191
Biochim Biophys Acta. 2016 Dec;1863(12):2977-2992
pubmed: 27646922
J Exp Med. 2000 Oct 2;192(7):977-86
pubmed: 11015439
J Immunol Methods. 1995 Jul 17;184(1):39-51
pubmed: 7622868
Phytomedicine. 2018 Aug 1;47:143-150
pubmed: 30166099
Int J Mol Sci. 2018 Jul 07;19(7):
pubmed: 29986516
Parasitol Res. 2011 Apr;108(4):861-71
pubmed: 21085992
J Chromatogr A. 2017 Mar 31;1491:126-136
pubmed: 28256253
Front Cell Infect Microbiol. 2019 Jun 14;9:208
pubmed: 31259161
Parasitol Int. 2014 Feb;63(1):21-30
pubmed: 24103199
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Front Plant Sci. 2015 Aug 25;6:655
pubmed: 26379683
Cytometry. 2000 Aug 1;40(4):353-60
pubmed: 10918286
Future Microbiol. 2015;10(5):763-89
pubmed: 26000650
Virulence. 2011 May-Jun;2(3):253-6
pubmed: 21566464
J Cell Biol. 2009 Jun 1;185(5):917-28
pubmed: 19487458
Parasite. 2014;21:15
pubmed: 24717526
Lancet. 2018 Sep 15;392(10151):951-970
pubmed: 30126638
Antimicrob Agents Chemother. 2004 Mar;48(3):852-9
pubmed: 14982775
Cell Death Differ. 2009 Jan;16(1):3-11
pubmed: 18846107
Phytomedicine. 2013 Feb 15;20(3-4):275-81
pubmed: 23273752
J Biol Chem. 2003 Nov 7;278(45):44708-18
pubmed: 12944391
Exp Parasitol. 2015 Apr-May;151-152:84-95
pubmed: 25655407
Parasitol Res. 2013 Jun;112(6):2269-80
pubmed: 23519426
Parasite Immunol. 2009 Oct;31(10):623-30
pubmed: 19751474
Genes Dev. 2000 Jul 15;14(14):1693-711
pubmed: 10898785